Biological Drug

DRUG5 trials

Sponsors

Assiut University, Universitaire Ziekenhuizen KU Leuven, Sohag University, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), IRCCS Burlo Garofolo

Conditions

AsthmaCrohn DiseaseJuvenile Chronic ArthritisRheumatoid ArthritisUlcerative Colitis

Phase 4

Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy

RecruitingNCT05169593

Universitaire Ziekenhuizen KU LeuvenCrohn Disease

Start: 2022-09-08End: 2030-10-01Target: 292Updated: 2026-05-05

Unknown Phase

Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis

Assiut UniversityUlcerative Colitis

Start: 2021-04-01End: 2022-06-01Target: 24Updated: 2021-03-29

Outcomes of Biological Therapy on Rheumatoid Arthritis

Sohag UniversityRheumatoid Arthritis

Start: 2022-06-30End: 2023-10-31Target: 200Updated: 2022-03-21

Fluctuation Analyses of Asthma Patients With Biologics Use

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Asthma

Start: 2023-12-31End: 2024-09-30Target: 48Updated: 2023-11-01

Articular Damage in Patients With Juvenile Idiopathic Arthritis After Transition to Adult Care

Not yet recruitingNCT06895278

IRCCS Burlo GarofoloJuvenile Chronic Arthritis

Start: 2025-04-01End: 2025-12-31Target: 100Updated: 2025-03-26

Related Papers

OP13 Postoperative Crohn’s disease recurrence: unanswered questions and future directions in diagnosis, pathophysiology, prevention and treatment. Conclusions from the 8th ECCO Scientific workshop.

Journal of Crohn s and Colitis2023-01-30